Reckitt Benckiser Group Stock Rating Reaffirmed by AlphaValue (RB)
Reckitt Benckiser Group (LON:RB)‘s stock had its “reduce” rating reaffirmed by AlphaValue in a research note issued on Thursday, American Banking News reports. They currently have a GBX 4,235 ($67.94) price target on the stock. AlphaValue’s target price would suggest a potential downside of 0.82% from the company’s current price.
Shares of Reckitt Benckiser Group (LON:RB) traded up 0.70% on Thursday, hitting GBX 4300.00. The stock had a trading volume of 697,261 shares. Reckitt Benckiser Group has a 1-year low of GBX 3564.00 and a 1-year high of GBX 4986.00. The stock’s 50-day moving average is GBX 4508.81 and its 200-day moving average is GBX 4644.. The company’s market cap is £31.413 billion.
Other equities research analysts have also recently issued reports about the stock. Analysts at Credit Suisse reiterated a “neutral” rating on shares of Reckitt Benckiser Group in a research note to investors on Wednesday. They now have a GBX 4,650 ($74.60) price target on the stock. Separately, analysts at Liberum Capital reiterated a “sell” rating on shares of Reckitt Benckiser Group in a research note to investors on Monday. Finally, analysts at Oriel Securities Ltd reiterated a “buy” rating on shares of Reckitt Benckiser Group in a research note to investors on Thursday, October 3rd. They now have a GBX 5,200 ($83.43) price target on the stock. Eight investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and six have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of GBX 4,617.57 ($74.08).
Reckitt Benckiser Group Plc is manufacturer and marketer of branded products in household, health and personal care, selling a range through over 60 operating companies into nearly 200 countries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.